Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience

Meningococcal diseases are serious threats to global health, and new vaccines specifically tailored to meet the age-related needs of various geographical areas are required. This paper focuses on the meningococcal conjugate vaccines developed by GSK Biologicals. Two combined conjugate vaccines were...

Full description

Saved in:
Bibliographic Details
Main Authors: Miller, Jacqueline M., Mesaros, Narcisa, Van Der Wielen, Marie, Baine, Yaela
Format: Artigo
Language:Inglês
Published: SAGE-Hindawi Access to Research 2011
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3170757/
https://ncbi.nlm.nih.gov/pubmed/21991444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/846756
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items